1. Grundy, S.M., J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith Jr., J.A. Spertus, F. Costa, American Heart Association, and National Heart, Lung, and Blood Institute. 2005. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112(17): 2735–2752.
2. WRITING GROUP MEMBERS, D. Lloyd-Jones, R.J. Adams, T.M. Brown, M. Carnethon, S. Dai, G. De Simone, T.B. Ferguson, E. Ford, K. Furie, C. Gillespie, A. Go, K. Greenlund, N. Haase, S. Hailpern, P.M. Ho, V. Howard, B. Kissela, S. Kittner, D. Lackland, L. Lisabeth, A. Marelli, M.M. McDermott, J. Meigs, D. Mozaffarian, M. Mussolino, G. Nichol, V.L. Roger, W. Rosamond, R. Sacco, P. Sorlie, V.L. Roger, T. Thom, S. Wasserthiel-Smoller, N.D. Wong, J. Wylie-Rosett, and American Heart Association Statistics Committee and Stroke Statistics Subcommittee. 2010. Heart disease and stroke statistics—2010 update: A report from the American Heart Association. Circulation 121(7): e46–e215.
3. Gradman, A.H., J.N. Basile, B.L. Carter, G.L. Bakris, and American Society of Hypertension Writing Group. 2010. Combination therapy in hypertension. Journal of the American Society of Hypertension 4(1): 42–50.
4. Wald, D.S., M. Law, J.K. Morris, J.P. Bestwick, and N.J. Wald. 2009. Combination therapy versus monotherapy in reducing blood pressure: Meta-analysis on 11,000 participants from 42 trials. American Journal of Medicine 122(3): 290–300.
5. de la Sierra, A., and M. Volpe. 2013. Olmesartan-based therapies: An effective way to improve blood pressure control and cardiovascular protection. Journal of Hypertension 31(1): S13–S17.